CEACAM5 and malignant colon neoplasm: These properties have made CEACAM5 a prominent clinical cancer biomarker, widely used in early diagnosis, effective prognosis, and monitoring of colon cancer, as well as other types of cancers (Gaglia et al. 1988; Ballesta et al. 1995).